Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial - EMPATICC (INCOR1)

NCT05636774 is registered in ClinicalTrials.gov with University Hospital, Essen as lead sponsor.

NCT NCT05636774
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05636774 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Empower the Heart of Patients With Terminal Cancer Using Cardiac Medicines Trial - EMPATICC (INCOR1)
Lead sponsor
University Hospital, Essen
Phase
Not applicable
Overall status
Completed
Start date
December 12, 2022
Completion date
March 1, 2025
Enrollment
97 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

patients with advanced cancer receiving specialized palliative care